Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 9;11(1):319.
doi: 10.1186/s40359-023-01355-4.

The role of stigma and depression in the reduced adherence among young breast cancer patients in Hungary

Gabriella Vizin  1 , Tamás Szekeres  2 , Anita Juhász  3 , Lilla Márton  4 , Magdolna Dank  5 , Dóra Perczel-Forintos  2 , Róbert Urbán  4
Affiliations

The role of stigma and depression in the reduced adherence among young breast cancer patients in Hungary

Gabriella Vizin et al. BMC Psychol. .

Abstract

Background: The main aim of our study was to investigate the role of depression, stigmatization, body shame and self-compassion in the adherence of young Hungarian breast cancer patients aged between 18 and 45 years.

Methods: In a cross-sectional online survey, data were collected from 99 young breast cancer patients (BC). Participants completed self-report questionnaires on socio-demographic and cancer-specific parameters as well as psychological factors (adherence: 12-item Medication Adherence Scale; depression: Hospital Anxiety and Depression Scale; stigmatization: Stigma Scale for Chronic Illnesses; body shame: Experience of Shame Scale; self-compassion: Self-Compassion Scale). We tested the predictors and mediators of adherence using hierarchical regression, mediation and moderation analysis among BC patients.

Results: We found that adherence was significantly associated with body shame and stigmatization in our BC sample. In addition, stigmatization alone was a significant predictor of lower adherence. Finally, in mediation models, where body shame was a mediator, we found a significant direct effect between stigma and adherence, in other words body shame had a significant mediating effect between these variables. According to our moderation analysis, self-compassion as a significant moderator acts as a protective factor in the linear relationship between stigma and lower adherence.

Conclusions: Our results highlight the importance of stigma and body shame in the development of adherence in oncological care among young Hungarian BC patients aged between 18 and 45 years. Assessment of stigma, body shame, self-compassion, and the improvement of the availability of evidence-based psychological interventions may increase the adherence of young Hungarian BC patients, leading to more favourable rates of survival.

Keywords: Adherence; Body shame; Breast cancer; Depression; Self-compassion; Stigma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The relationship of stigma through body shame to adherence Note: * p < 0.05; *** p < 0.001
Fig. 2
Fig. 2
The moderating effect of self-compassion in the association of stigmatization with reduced adherence
See this image and copyright information in PMC

References

    1. GLOBOCAN. (2020). France: The International Agency for Research on Cancer. http://globocan.iarc.fr Accessed 20 Feb 2020.
    1. Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study. The Lancet. 2015;385(9974):1206–18. - PubMed
    1. Winters S, Martin C, Murphy D, Shokar NK. (2017). Breast cancer epidemiology, prevention, and screening. Progress in molecular biology and translational science, 151, 1–32. - PubMed
    1. World Health Organization. WHO position paper on mammography screening. World Health Organization; 2014. - PubMed
    1. Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, Neugut AI. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126:529–37. - PMC - PubMed